Cardiovascular disease and osteoporosis

Area of Science:

• Biomedical science
• Public health
• Gerontology

Background:

• Cardiovascular disease (CVD) and osteoporosis (OP) are significant public health concerns with established epidemiological links.
• Reduced bone mineral density (BMD) and fractures are increasingly associated with CVD and cardiovascular mortality.
• Shared pathophysiological mechanisms and risk factors may underlie the co-occurrence of CVD and OP.

Purpose of the Study:

• To explore the intricate relationship between cardiovascular disease and osteoporosis.
• To identify common pathophysiological mechanisms, risk factors, and molecular determinants linking CVD and OP.
• To review the role of matrix proteins, hormonal factors (estrogen), and therapeutic agents in the interplay between CVD and OP.

Main Methods:

• Literature review and synthesis of existing epidemiological and clinical studies.
• Analysis of the roles of shared matrix proteins (e.g., type 1 collagen) in bone and vascular health.
• Examination of hormonal influences, particularly estrogen's impact on cytokines (IL-1, IL-6, TNF-alpha) and osteoprotegerin (OPG).

Main Results:

• Matrix proteins are crucial in both bone formation and atherosclerosis development.
• Estrogen deficiency exacerbates bone loss and atherogenesis by altering cytokine profiles and OPG levels.
• Certain drugs (bisphosphonates, statins, raloxifene) may exhibit overlapping cellular mechanisms affecting both bone and vascular systems.

Conclusions:

• CVD and OP are interconnected conditions influenced by common molecular pathways and risk factors.
• Further research is essential to elucidate the complex interactions and develop targeted therapeutic strategies.
• Understanding these links can lead to integrated approaches for managing patients with both cardiovascular and bone diseases.